{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T01:40:21Z","timestamp":1782351621152,"version":"3.54.5"},"reference-count":40,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Kiniksa Pharmaceuticals"},{"DOI":"10.13039\/100001582","name":"Dermatology Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001582","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005614","name":"Biogen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005614","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Eli Lilly"},{"DOI":"10.13039\/100006436","name":"Celgene","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006436","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001582","name":"Dermatology Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001582","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.jaad.2019.09.017","type":"journal-article","created":{"date-parts":[[2019,9,19]],"date-time":"2019-09-19T19:07:15Z","timestamp":1568920035000},"page":"303-310","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Predictors of 30-day readmission in Stevens-Johnson syndrome and toxic epidermal necrolysis: A cross-sectional database study"],"prefix":"10.1016","volume":"82","author":[{"given":"Anthony K.","family":"Guzman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myron","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shawn G.","family":"Kwatra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin H.","family":"Kaffenberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaad.2019.09.017_bib1","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/sj.jid.5701033","article-title":"Stevens-Johnson syndrome and toxic epidermal necrolysis: assessment of medication risks with emphasis on recently marketed drugs. The EuroSCAR-study","volume":"128","author":"Mockenhaupt","year":"2008","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaad.2019.09.017_bib2","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1016\/j.jid.2017.01.031","article-title":"The epidemiology of Stevens-Johnson syndrome and toxic epidermal necrolysis in the UK","volume":"137","author":"Frey","year":"2017","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaad.2019.09.017_bib3","doi-asserted-by":"crossref","first-page":"e0165933","DOI":"10.1371\/journal.pone.0165933","article-title":"Incidence of Stevens-Johnson syndrome and toxic epidermal necrolysis: a nationwide population-based study using National Health Insurance Database in Korea","volume":"11","author":"Yang","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.jaad.2019.09.017_bib4","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/0895-4356(96)00035-2","article-title":"Epidemiology of erythema exsudativum multiforme majus, Stevens-Johnson syndrome, and toxic epidermal necrolysis in Germany (1990-1992): structure and results of a population-based registry","volume":"49","author":"Rzany","year":"1996","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.jaad.2019.09.017_bib5","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1038\/jid.2012.510","article-title":"Comprehensive survival analysis of a cohort of patients with Stevens-Johnson syndrome and toxic epidermal necrolysis","volume":"133","author":"Sekula","year":"2013","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaad.2019.09.017_bib6","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1590\/abd1806-4841.20196864","article-title":"Epidermal necrolysis: SCORTEN performance in AIDS and non-AIDS patients","volume":"94","author":"Wambier","year":"2019","journal-title":"An Bras Dermatol"},{"key":"10.1016\/j.jaad.2019.09.017_bib7","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1111\/pde.13172","article-title":"Score of toxic epidermal necrosis predicts the outcomes of pediatric epidermal necrolysis","volume":"34","author":"Sorrell","year":"2017","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.jaad.2019.09.017_bib8","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1111\/j.1468-3083.2012.04502.x","article-title":"SCORTEN and impaired renal function related to mortality of toxic epidermal necrolysis syndrome patients in the Asian population","volume":"27","author":"Hu","year":"2013","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaad.2019.09.017_bib9","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1001\/jamadermatol.2018.5605","article-title":"Development and validation of a risk prediction model for in-hospital mortality among patients with Stevens-Johnson syndrome\/toxic epidermal necrolysis-ABCD-10","volume":"155","author":"Noe","year":"2019","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jaad.2019.09.017_bib10","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1002\/pds.3778","article-title":"Identification of Stevens-Johnson syndrome and toxic epidermal necrolysis in electronic health record databases","volume":"24","author":"Davis","year":"2015","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.jaad.2019.09.017_bib11","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.jaad.2016.12.024","article-title":"Pediatric Stevens-Johnson syndrome and toxic epidermal necrolysis in the United States","volume":"76","author":"Hsu","year":"2017","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2019.09.017_bib12","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1097\/01.mlr.0000182534.19832.83","article-title":"Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data","volume":"43","author":"Quan","year":"2005","journal-title":"Med Care"},{"key":"10.1016\/j.jaad.2019.09.017_bib13","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1097\/00005650-199801000-00004","article-title":"Comorbidity measures for use with administrative data","volume":"36","author":"Elixhauser","year":"1998","journal-title":"Med Care"},{"key":"10.1016\/j.jaad.2019.09.017_bib14","doi-asserted-by":"crossref","first-page":"e0180767","DOI":"10.1371\/journal.pone.0180767","article-title":"Short-term rehospitalization across the spectrum of age and insurance types in the United States","volume":"12","author":"Strom","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.jaad.2019.09.017_bib15","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.jaad.2019.05.023","article-title":"Dermatology-specific and all-cause 30-day and calendar-year readmissions and costs for dermatologic diseases from. 2010-2014","volume":"81","author":"Zhang","year":"2019","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2019.09.017_bib16","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1016\/j.burns.2018.03.006","article-title":"Toxic epidermal necrolysis data from the CELESTE multinational registry. Part II: specific systemic and local risk factors for the development of infectious complications","volume":"44","author":"Lipovy","year":"2018","journal-title":"Burns"},{"key":"10.1016\/j.jaad.2019.09.017_bib17","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1111\/j.1468-3083.2011.04143.x","article-title":"Toxic epidermal necrolysis and Stevens-Johnson syndrome at the Prague Burn\u00a0Centre 1998-2008","volume":"26","author":"Zajicek","year":"2012","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaad.2019.09.017_bib18","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1111\/j.1468-3083.2006.02082.x","article-title":"Toxic epidermal necrolysis: 15 years' experience in a Dutch burns centre","volume":"21","author":"Gerdts","year":"2007","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaad.2019.09.017_bib19","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1111\/j.1365-2230.2010.03826.x","article-title":"Toxic epidermal necrolysis: retrospective analysis of 21 consecutive cases managed at a tertiary centre","volume":"35","author":"Rajaratnam","year":"2010","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.jaad.2019.09.017_bib20","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1097\/01.BCR.0000150215.78220.79","article-title":"Late outcomes in adult survivors of toxic epidermal necrolysis after treatment in a burn center","volume":"26","author":"Haber","year":"2005","journal-title":"J Burn Care Rehabil"},{"key":"10.1016\/j.jaad.2019.09.017_bib21","doi-asserted-by":"crossref","first-page":"49","DOI":"10.2165\/11593240-000000000-00000","article-title":"Incidence of toxic epidermal necrolysis and Stevens-Johnson Syndrome in an HIV cohort: an observational, retrospective case series study","volume":"13","author":"Mittmann","year":"2012","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.jaad.2019.09.017_bib22","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1046\/j.1523-1747.2000.00061.x","article-title":"SCORTEN: a severity-of-illness score for toxic epidermal necrolysis","volume":"115","author":"Bastuji-Garin","year":"2000","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaad.2019.09.017_bib23","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1001\/archderm.1987.01660330071012","article-title":"Toxic epidermal necrolysis. Clinical findings and prognosis factors in 87 patients","volume":"123","author":"Revuz","year":"1987","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2019.09.017_bib24","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1097\/CCM.0b013e31829eb94f","article-title":"Acute respiratory failure in patients with toxic epidermal necrolysis: clinical features and factors associated with mechanical ventilation","volume":"42","author":"de Prost","year":"2014","journal-title":"Crit Care Med"},{"key":"10.1016\/j.jaad.2019.09.017_bib25","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1111\/bjd.14799","article-title":"Major psychological complications and decreased health-related quality of life among survivors of Stevens-Johnson syndrome and toxic epidermal necrolysis","volume":"175","author":"Dodiuk-Gad","year":"2016","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2019.09.017_bib26","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1007\/s11606-013-2440-2","article-title":"Impact of specialist consultations on inpatient admissions for dermatology-specific and related DRGs","volume":"28","author":"Hu","year":"2013","journal-title":"J Gen Intern Med"},{"key":"10.1016\/j.jaad.2019.09.017_bib27","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.jaad.2009.06.030","article-title":"Dermatology inpatient consultations: a\u00a0retrospective study","volume":"62","author":"Bauer","year":"2010","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2019.09.017_bib28","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1001\/jama.2017.5702","article-title":"Association between teaching status and mortality in US hospitals","volume":"317","author":"Burke","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/j.jaad.2019.09.017_bib29","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1097\/MLR.0000000000000005","article-title":"Hospital teaching intensity and mortality for acute myocardial infarction, heart failure, and pneumonia","volume":"52","author":"Shahian","year":"2014","journal-title":"Med Care"},{"key":"10.1016\/j.jaad.2019.09.017_bib30","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1097\/ACM.0b013e318253676a","article-title":"Contemporary performance of U.S. teaching and nonteaching hospitals","volume":"87","author":"Shahian","year":"2012","journal-title":"Acad Med"},{"key":"10.1016\/j.jaad.2019.09.017_bib31","first-page":"e253","article-title":"Association between length of stay and readmission for COPD","volume":"23","author":"Rinne","year":"2017","journal-title":"Am J Manag Care"},{"key":"10.1016\/j.jaad.2019.09.017_bib32","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.jchf.2017.03.012","article-title":"Associations between short or long length of stay and 30-day readmission and mortality in hospitalized patients with heart failure","volume":"5","author":"Sud","year":"2017","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.jaad.2019.09.017_bib33","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1111\/1475-6773.00042","article-title":"Do hospital length of stay and staffing ratio affect elderly patients' risk of readmission? A nation-wide study of Norwegian hospitals","volume":"37","author":"Heggestad","year":"2002","journal-title":"Health Serv Res"},{"key":"10.1016\/j.jaad.2019.09.017_bib34","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1002\/hec.3061","article-title":"Measuring the hospital length of stay\/readmission cost trade-off under a bundled payment mechanism","volume":"24","author":"Carey","year":"2015","journal-title":"Health Econ"},{"key":"10.1016\/j.jaad.2019.09.017_bib35","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/j.amepre.2018.12.003","article-title":"national 90-day readmissions after opioid overdose discharge","volume":"56","author":"Peterson","year":"2019","journal-title":"Am J Prev Med"},{"key":"10.1016\/j.jaad.2019.09.017_bib36","doi-asserted-by":"crossref","first-page":"e697","DOI":"10.1016\/j.wneu.2019.03.245","article-title":"Predictors of 90-day readmission in children undergoing spinal cord tumor surgery: a Nationwide Readmissions Database analysis","volume":"127","author":"Janjua","year":"2019","journal-title":"World Neurosurg"},{"key":"10.1016\/j.jaad.2019.09.017_bib37","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1111\/1475-6773.13133","article-title":"Adjusting for social\u00a0risk factors impacts performance and penalties in the hospital readmissions reduction program","volume":"54","author":"Joynt Maddox","year":"2019","journal-title":"Health Serv Res"},{"key":"10.1016\/j.jaad.2019.09.017_bib38","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1001\/jamadermatol.2018.3114","article-title":"Association of demographic and socioeconomic characteristics with differences in use of outpatient dermatology services in the United States","volume":"154","author":"Tripathi","year":"2018","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jaad.2019.09.017_bib39","doi-asserted-by":"crossref","first-page":"161","DOI":"10.7326\/0003-4819-138-3-200302040-00007","article-title":"The incidence and severity of adverse events affecting patients after discharge from the hospital","volume":"138","author":"Forster","year":"2003","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jaad.2019.09.017_bib40","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1001\/jama.2015.6507","article-title":"The Medicare Hospital Readmissions Reduction Program: time for reform","volume":"314","author":"Boozary","year":"2015","journal-title":"JAMA"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962219327549?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962219327549?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T22:53:05Z","timestamp":1759272785000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962219327549"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":40,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["S0190962219327549"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2019.09.017","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Predictors of 30-day readmission in Stevens-Johnson syndrome and toxic epidermal necrolysis: A cross-sectional database study","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2019.09.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 by the American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}